Dissolution properties of praziquantel-β-cyclodextrin systems

Pharmaceutical Development and Technology

Volumn 1, Issue 3, 1996, Pages 307-315

  Ei Arini, Silvia Kocova ^a   Leuenberger, Hans ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Drug loading; DSC; Percolation theory; Physical mixtures; Praziquantel release; Solid inclusions; cyclodextrin

Indexed keywords

ANTISCHISTOSOMAL AGENT; BETA CYCLODEXTRIN; KLEPTOSE; POLYMER; PRAZIQUANTEL; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; DRUG RELEASE; DRUG SOLUBILITY; KINETICS; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; THEORY;

BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHYSICAL; CYCLODEXTRINS; PRAZIQUANTEL; SCHISTOSOMICIDES; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; THERMODYNAMICS;

EID: 0030317064     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459609022600     Document Type: Article

References (24)

1. W. L. Chiou and S. Riegelman, Pharmaceutical applications of solid dispersion systems, J. Pharm. Sci., 60, 1281-1302 (1971).
2. O. I. Corrigan and C. T. Stanley, Dissolution properties of phenobarbitone-β-cyclodextrin systems, Pharm Acta Helv., 56, 204-208 (1981).
3. J. Szejtli and L. Szente, Interactions between indomethacin and β-cyclodextrin, Pharmazie, 36, 694-698 (1981).
4. M. Kata and M. Lukacs, Preparation and investigation of hydrochlorothiazide products containing β-cyctodextrin, Pharmazie, 39, 857-858 (1984).
5. I. Habon, S. Fritsch, and J. Szejtli, Simulation of pharmacokinetic behavior of drug-cyclodextrin complexes, Pharmazie, 39, 830-834 (1984).
6. J. P. Couland and G. Charmot, Le treatment des Bilharzioses, Rev. Prat., 43, 453-456 (1993) .
7. R. N. H. Pough and C. H. Teesdale, Synergy of concurrent low dose oxamniquine and praziquantel in schistosomiasis, Br. Med. J., 287, 877-878 (1983).
8. S. Kaojarern, S. Nathakarnkikool, and U. Suvanakoot, Comparative bioavailability of praziquantel tablets, DICP, Ann. Pharmacother., 23, 29-32 (1989).
9. M. E. M. Mandour, H. E. Turabi, M. M. A. Homeida, T. Sadig, H. M. Ali, J. L. Bennett, W. J. Leahey, and D. W. G. Harron, Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis, Trans. Roy. Soc. Trop. Med. Hyg., 84, 389-393 (1990).
10. M. Akbarieh, J. G. Besner, A. Galal, and R. Tawashi, Liposomal delivery system for the targeting and controlled release of praziquantel, Drug Dev. Ind. Pharm., 18, 303-317 (1992).
11. J. D. Bonny, Wirkstofffreisetzung aus Matrix-Retardformen: Die Bedeutung der fraktalen Geometrie und der Perkolationstheorie, Ph.D. thesis, University of Basel, (1992).
12. T. Higuchi and K. A. Connors, Phase-solubility techniques, Adv. Anal. Che. Instrument., 4, 117-212 (1965).
13. J. Blanco, J. L. Vila-Jato, F. Otero, and S. Anguiano, Influence of method of preparation on inclusion complexes of naproxen with different cyclodextrins, Drug Dev. Ind. Pharm., 17, 943-957 (1991).
14. R. J. Prankerd and S. M. Ahmed, Physicochemical interactions of praziquantel, oxamniquine and tablet excipients, J. Pharm. Pharmacol., 44, 259-261 (1992).
15. U.S. Pharmacopoeia 23, National Formulary 18, 1995, p. 1274.
16. Merck Index, 10th ed., Merck and Co., Rahway, NJ, No. 7609.
17. T. Higuchi, Mechanism of sustained action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci., 52, 1145-1149 (1963).
18. N. A. Peppas and J. J. Sahlin, A simple equation for the description of solute release. III. Coupling of diffusion and relaxation, Int. J. Pharm., 57, 169-172 (1989).
19. R. W. Korsmeyer, R. Gumy, E. Doelker, P. Buri, and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm., 15, 23-35 (1983).
20. S. K. El-Arini and H. Leuenberger, Modelling of drug release from polymer matrices: Effect of drug loading, Int. J. Pharm., 121, 141-148 (1995).
21. D. Stauffer and A. Aharony, Introduction to Percolation Theory. 2nd ed., Taylor and Francis, London, 1992.
22. J. D. Bonny and H. Leuenberger, Matrix type controlled release systems. I. Effect of percolation on drug dissolution kinetics, Pharm. Acta Helv., 66, 160-164 (1991).
23. R. Luginbühl, Anwendung der Perkolationstheorie zur Untersuchung des Zerfallsproresses, der Wasseraufnahme und der Wirkstofffreisetzung von binären Tablettensystemen, Ph.D. thesis, University of Basel (1994).
24. R. Luginbühl and H. Leuenberger, Use of percolation theory to interpret water uptake, disintegration time and intrinsic dissolution rate of tablets consisting of binary mixtures, Pharm. Acta Helv., 69, 127-134 (1994).